ID-Specific Donor Vaccinated Lymphocyte Infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ID-Specific Donor Vaccinated Lymphocyte Infusion, covering 2018-06-01 to 2018-06-01. Get the full timeline:
Most recent: Clinical Trial Update: Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant [Phase 2]